These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 15785896
1. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients. Roumen RM, Slooter GD, Croiset van Uchelen FA, Huib LV. Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896 [Abstract] [Full Text] [Related]
2. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients. Alabi AA, Suppiah A, Madden LA, Monson JR, Greenman J. Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868 [Abstract] [Full Text] [Related]
3. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer. Tsai WS, Changchien CR, Yeh CY, Chen JS, Tang R, Chiang JM, Hsieh PS, Fan CW, Wang JY. Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643 [Abstract] [Full Text] [Related]
4. Circulating vascular endothelial growth factor in patients with colorectal cancer. Fujisaki K, Mitsuyama K, Toyonaga A, Matsuo K, Tanikawa K. Am J Gastroenterol; 1998 Feb; 93(2):249-52. PubMed ID: 9468253 [Abstract] [Full Text] [Related]
5. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer. Miyazaki T, Okada N, Ishibashi K, Ogata K, Ohsawa T, Ishiguro T, Nakada H, Yokoyama M, Matsuki M, Kato H, Kuwano H, Ishida H. Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001 [Abstract] [Full Text] [Related]
6. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D, Nürnberg R, Bahlo M, Klapdor R. Anticancer Res; 1999 Dec; 19(4A):2443-50. PubMed ID: 10470173 [Abstract] [Full Text] [Related]
7. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H. Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401 [Abstract] [Full Text] [Related]
8. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers. Takeda A, Shimada H, Imaseki H, Okazumi S, Natsume T, Suzuki T, Ochiai T. Oncol Rep; 2000 Dec; 7(2):333-8. PubMed ID: 10671682 [Abstract] [Full Text] [Related]
9. Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes a and B colorectal cancer: results of a five-year study. Miki C, Inoue Y, Hiro J, Ojima E, Araki T, Uchida K, Kusunoki M. Dis Colon Rectum; 2006 Nov; 49(11):1710-8. PubMed ID: 16990975 [Abstract] [Full Text] [Related]
10. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer. Chin KF, Greenman J, Gardiner E, Kumar H, Topping K, Monson J. Br J Cancer; 2000 Dec; 83(11):1425-31. PubMed ID: 11076648 [Abstract] [Full Text] [Related]
11. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer? Broll R, Erdmann H, Duchrow M, Oevermann E, Schwandner O, Markert U, Bruch HP, Windhövel U. Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490 [Abstract] [Full Text] [Related]
12. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection. Tang R, Yeh CY, Wang JY, Changchien CR, Chen JS, Hsieh LL. Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285 [Abstract] [Full Text] [Related]
13. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients. Famulski W, Sulkowska M, Wincewicz A, Kedra B, Pawlak K, Zalewski B, Sulkowski S, Koda M, Baltaziak M. Neoplasma; 2006 Sep; 53(1):43-8. PubMed ID: 16416012 [Abstract] [Full Text] [Related]
14. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma. Tamesa T, Iizuka N, Mori N, Okada T, Takemoto N, Tangoku A, Oka M. Hepatogastroenterology; 2009 Sep; 56(93):1122-6. PubMed ID: 19760954 [Abstract] [Full Text] [Related]
15. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer]. Gonda T, Okada N, Nakada H, Yokoyama M, Miyazaki T, Ishibashi K, Ishida H, Matsumoto Y, Miura T. Gan To Kagaku Ryoho; 2006 Nov; 33(12):1841-4. PubMed ID: 17212123 [Abstract] [Full Text] [Related]
16. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E. Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor. Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Watanabe G. J Thorac Cardiovasc Surg; 2004 Oct; 128(4):517-22. PubMed ID: 15457151 [Abstract] [Full Text] [Related]
20. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY. Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [Abstract] [Full Text] [Related] Page: [Next] [New Search]